Michelle McMurry-Heath brings a wide-ranging background in medicine, immunology, research, and policy coordination to her current role as the chief executive officer for the Biotechnology Innovation Organization (BIO). She had a chat with Cell editor Cheri Sirois about how biotech differs from basic science and about the opportunities it offers.
Understanding this could lead to better treatments, improved diagnostics, or a deeper grasp of how the human body works — benefiting patient care globally.
Read the full paper
Access the original peer-reviewed research via PubMed.
| Category | 🧬 Medicine & Biology |
| Published | Jul 21, 2022 |
| Journal | Cell |
| DOI | 10.1016/j.cell.2022.06.022 |
| Source | PubMed |